GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Price-to-Owner-Earnings

CellSource Co (TSE:4880) Price-to-Owner-Earnings : 24.31 (As of May. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Price-to-Owner-Earnings?

As of today (2024-05-15), CellSource Co's share price is 円1432.00. CellSource Co's Owner Earnings per Share (TTM) ended in Oct. 2023 was 円58.91. It's Price-to-Owner-Earnings for today is 24.31.


The historical rank and industry rank for CellSource Co's Price-to-Owner-Earnings or its related term are showing as below:

TSE:4880' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.47   Med: 112.12   Max: 272.23
Current: 24.14

During the past 7 years, the highest Price-to-Owner-Earnings of CellSource Co was 272.23. The lowest was 20.47. And the median was 112.12.


TSE:4880's Price-to-Owner-Earnings is ranked better than
63.86% of 166 companies
in the Biotechnology industry
Industry Median: 34.09 vs TSE:4880: 24.14

As of today (2024-05-15), CellSource Co's share price is 円1432.00. CellSource Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was 円43.92. Therefore, CellSource Co's PE Ratio for today is 32.60.

As of today (2024-05-15), CellSource Co's share price is 円1432.00. CellSource Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円42.55. Therefore, CellSource Co's PE Ratio without NRI for today is 33.66.

During the past 7 years, CellSource Co's highest PE Ratio without NRI was 475.38. The lowest was 25.86. And the median was 114.32.


CellSource Co Price-to-Owner-Earnings Historical Data

The historical data trend for CellSource Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Price-to-Owner-Earnings Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - 232.21 115.81 30.27

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 30.27 -

Competitive Comparison of CellSource Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, CellSource Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CellSource Co's Price-to-Owner-Earnings falls into.



CellSource Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CellSource Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1432.00/58.91
=24.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CellSource Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CellSource Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines